{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T07:19:00Z","timestamp":1794727140754,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ygyno.2023.11.022","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T11:38:36Z","timestamp":1703590716000},"page":"91-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development and testing of patient-centered education about hormone replacement therapy for women at high genetic risk of breast and ovarian cancer"],"prefix":"10.1016","volume":"181","author":[{"given":"Katherine N.","family":"Penvose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby D.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Marcos Gonzalez","family":"Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Mastylak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Shank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Havrilesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ygyno.2023.11.022_bb0005","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"23","key":"10.1016\/j.ygyno.2023.11.022_bb0010","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast Cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA."},{"issue":"11","key":"10.1016\/j.ygyno.2023.11.022_bb0015","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.11.022_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkaa029","article-title":"Penetrance of Breast and Ovarian Cancer in Women Who Carry a BRCA1\/2 Mutation and Do Not Use Risk-Reducing Salpingo-Oophorectomy: An Updated Meta-Analysis","volume":"4","author":"Chen","year":"2020","journal-title":"JNCI Cancer Spectr."},{"issue":"1","key":"10.1016\/j.ygyno.2023.11.022_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: breast and ovarian, version 2.2017","volume":"15","author":"Daly","year":"2017","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"5","key":"10.1016\/j.ygyno.2023.11.022_bb0030","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/AOG.0000000000004364","article-title":"Controversies in hereditary Cancer management","volume":"137","author":"AlHilli","year":"2021","journal-title":"Obstet. Gynecol."},{"issue":"14","key":"10.1016\/j.ygyno.2023.11.022_bb0035","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.3390\/cancers14143457","article-title":"Contraception and hormone replacement therapy in healthy carriers of germline BRCA1\/2 genes pathogenic variants: results from an Italian survey","volume":"14","author":"Massarotti","year":"2022","journal-title":"Cancers (Basel)."},{"issue":"1","key":"10.1016\/j.ygyno.2023.11.022_bb0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/GME.0000000000001432","article-title":"Menopausal hormone therapy for BRCA-mutation carriers: attitudes of Israeli healthcare providers before and after a brief educational intervention","volume":"27","author":"Perri","year":"2020","journal-title":"Menopause."},{"issue":"1","key":"10.1016\/j.ygyno.2023.11.022_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/bjc.2011.202","article-title":"Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT","volume":"105","author":"Challberg","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"14","key":"10.1016\/j.ygyno.2023.11.022_bb0050","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"issue":"9470","key":"10.1016\/j.ygyno.2023.11.022_bb0055","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Endometrial cancer and hormone-replacement therapy in the Million Women Study","volume":"365","author":"Beral","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ygyno.2023.11.022_bb0060","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis","volume":"85","author":"Grady","year":"1995","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.11.022_bb0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bpobgyn.2020.05.003","article-title":"Progesterone and endometrial cancer","volume":"69","author":"Gompel","year":"2020","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.11.022_bb0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing Group for the Women\u2019s health initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA."},{"issue":"10","key":"10.1016\/j.ygyno.2023.11.022_bb0075","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/pon.5714","article-title":"BRCA mutation carriers\u2019 perceptions on postmenopausal hormone therapy: An Italian study","volume":"30","author":"Grandi","year":"2021","journal-title":"Psychooncology"},{"issue":"7565","key":"10.1016\/j.ygyno.2023.11.022_bb0080","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/bmj.38926.629329.AE","article-title":"Developing a quality criteria framework for patient decision aids: online international Delphi consensus process","volume":"333","author":"Elwyn","year":"2006","journal-title":"BMJ."},{"issue":"1","key":"10.1016\/j.ygyno.2023.11.022_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/0272989X9501500105","article-title":"Validation of a decisional conflict scale","volume":"15","author":"O\u2019Connor","year":"1995","journal-title":"Med. Decis. Mak."},{"key":"10.1016\/j.ygyno.2023.11.022_bb0090","series-title":"User Manual - Decisional Conflict Scale (16 Item Statement Format) [Document on the Internet]","author":"O\u2019Connor","year":"1993"},{"issue":"1","key":"10.1016\/j.ygyno.2023.11.022_bb0095","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2018.12.014","article-title":"Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits","volume":"153","author":"Gordhandas","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2023.11.022_bb0100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/medicina55080415","article-title":"Risk-reducing bilateral Salpingo-oophorectomy for BRCA mutation carriers and hormonal replacement therapy: if it should rain, better a drizzle than a storm","volume":"55","author":"Gasparri","year":"2019","journal-title":"Medicina (Kaunas)"},{"issue":"8","key":"10.1016\/j.ygyno.2023.11.022_bb0105","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00005650-199508000-00003","article-title":"Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia","volume":"33","author":"Barry","year":"1995","journal-title":"Med. Care"},{"key":"10.1016\/j.ygyno.2023.11.022_bb0110","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jmp.2005.05.003","article-title":"Some probabilistic models of best, worst, and best-worst choices","volume":"49","author":"Marley","year":"2005","journal-title":"J. Math. Psychol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.11.022_bb0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40120-023-00445-0","article-title":"Assessing what matters to people affected by alzheimer\u2019s disease: a quantitative analysis","volume":"12","author":"Hauber","year":"2023","journal-title":"Neurol. Ther."},{"issue":"8","key":"10.1016\/j.ygyno.2023.11.022_bb0120","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jamaoncol.2018.0211","article-title":"Hereditary breast Cancer clinical study group. Hormone replacement therapy after oophorectomy and breast Cancer risk among BRCA1 mutation carriers","volume":"4","author":"Kotsopoulos","year":"2018","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.11.022_bb0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygyno.2010.12.326","article-title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation","volume":"121","author":"Finch","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.11.022_bb0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/gme.0b013e31818888f7","article-title":"Increased cardiovascular mortality after early bilateral oophorectomy","volume":"16","author":"Rivera","year":"2009","journal-title":"Menopause."},{"issue":"1","key":"10.1016\/j.ygyno.2023.11.022_bb0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0378-5122(93)90122-X","article-title":"Reproductive factors as predictors of bone density and fractures in women at the age of 70","volume":"17","author":"Johansson","year":"1993","journal-title":"Maturitas."},{"issue":"7083","key":"10.1016\/j.ygyno.2023.11.022_bb0140","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/bmj.314.7083.796","article-title":"Hormone replacement therapy and risk of venous thromboembolism: population based case-control study","volume":"314","author":"P\u00e9rez Gutthann","year":"1997","journal-title":"BMJ."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823015664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823015664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:06:41Z","timestamp":1758773201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823015664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":28,"alternative-id":["S0090825823015664"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.11.022","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and testing of patient-centered education about hormone replacement therapy for women at high genetic risk of breast and ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}